Skip to main content

Table 1 Insulin dose adjustment for each study group

From: Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial

FPG (mmol/L)

Insulin dose

All groups ≤ 3.9 or nocturnal hypoglycemia

- 2 U

Group 1: 3.9 < FPG ≤ 5.6

No change

Group 2: 3.9 < FPG ≤ 6.1

Group 3: 3.9 < FPG ≤ 7.0

Group 1: FPG > 5.6

+2 U

Group 2: FPG > 6.1

Group 3: FPG > 7.0

  1. FPG fasting plasma glucose